• レポートコード:MRC2102QY12051 • 出版社/出版日: / 2021年1月 • レポート形態:英文、PDF、145ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医薬品、医療 |
Single User | ¥600,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥900,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界のラニチジン(ザンタック)市場について種類別(ラニチジンカプセル、ラニチジン経口錠剤、ラニチジン注射液、ラニチジン経口シロップ)、用途別(病院内薬局、小売薬局、オンライン薬局)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ラニチジン(ザンタック)市場の概要 ・世界の主要地域別ラニチジン(ザンタック)市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のラニチジン(ザンタック)市場規模2015-2026:種類別(ラニチジンカプセル、ラニチジン経口錠剤、ラニチジン注射液、ラニチジン経口シロップ) ・世界のラニチジン(ザンタック)市場規模2015-2026:用途別(病院内薬局、小売薬局、オンライン薬局) ・ラニチジン(ザンタック)の米国市場規模2015-2020 ・ラニチジン(ザンタック)のヨーロッパ市場規模2015-2020 ・ラニチジン(ザンタック)の中国市場規模2015-2020 ・ラニチジン(ザンタック)の日本市場規模2015-2020 ・ラニチジン(ザンタック)の東南アジア市場規模2015-2020 ・ラニチジン(ザンタック)のインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・ラニチジン(ザンタック)の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ラニチジン(ザンタック)の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Ranitidine (Zantac) Market
The global Ranitidine (Zantac) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Ranitidine (Zantac) Scope and Market Size
The global Ranitidine (Zantac) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ranitidine (Zantac) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Ranitidine (Zantac) market is segmented into
Ranitidine Capsule
Ranitidine Oral Tablet
Ranitidine Injectable Solution
Ranitidine Oral Syrup
Segment by Application, the Ranitidine (Zantac) market is segmented into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
The Ranitidine (Zantac) market is analysed and market size information is provided by regions (countries). Segment by Application, the Ranitidine (Zantac) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Ranitidine (Zantac) Market Share Analysis
Ranitidine (Zantac) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ranitidine (Zantac) business, the date to enter into the Ranitidine (Zantac) market, Ranitidine (Zantac) product introduction, recent developments, etc.
The major vendors covered:
Sanofi-Aventis
GlaxoSmithKline
Hi-Tech Pharmacal Co.
Sun Pharma
Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
Dr. Reddy’s Laboratories Inc.
Sandoz Inc. (part of Novartis AG)
Strides (and Strides Arcolab international)
Geri-Care Pharmaceuticals
PAI Holdings, LLC
Teva Pharmaceuticals
Granules Pharmaceuticals Inc.
Glenmark Pharmaceuticals (and Glenmark Generics)
Apotex Inc. (and Apotex Corporation)
Hikma Pharmaceuticals (West-ward Pharmaceuticals)
1 Ranitidine (Zantac) Market Overview
1.1 Ranitidine (Zantac) Product Scope
1.2 Ranitidine (Zantac) Segment by Type
1.2.1 Global Ranitidine (Zantac) Sales by Type (2020-2026)
1.2.2 Ranitidine Capsule
1.2.3 Ranitidine Oral Tablet
1.2.4 Ranitidine Injectable Solution
1.2.5 Ranitidine Oral Syrup
1.3 Ranitidine (Zantac) Segment by Application
1.3.1 Global Ranitidine (Zantac) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Ranitidine (Zantac) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Ranitidine (Zantac) Sales Growth Rate (2015-2026)
1.4.2 Global Ranitidine (Zantac) Revenue and Growth Rate (2015-2026)
1.4.3 Global Ranitidine (Zantac) Price Trends (2015-2026)
2 Ranitidine (Zantac) Estimate and Forecast by Region
2.1 Global Ranitidine (Zantac) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Ranitidine (Zantac) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Ranitidine (Zantac) Sales Market Share by Region (2015-2020)
2.2.2 Global Ranitidine (Zantac) Revenue Market Share by Region (2015-2020)
2.3 Global Ranitidine (Zantac) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Ranitidine (Zantac) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Ranitidine (Zantac) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Ranitidine (Zantac) Estimates and Projections (2015-2026)
2.4.2 Europe Ranitidine (Zantac) Estimates and Projections (2015-2026)
2.4.3 China Ranitidine (Zantac) Estimates and Projections (2015-2026)
2.4.4 Japan Ranitidine (Zantac) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Ranitidine (Zantac) Estimates and Projections (2015-2026)
2.4.6 India Ranitidine (Zantac) Estimates and Projections (2015-2026)
3 Global Ranitidine (Zantac) Competition Landscape by Players
3.1 Global Top Ranitidine (Zantac) Players by Sales (2015-2020)
3.2 Global Top Ranitidine (Zantac) Players by Revenue (2015-2020)
3.3 Global Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranitidine (Zantac) as of 2019)
3.4 Global Ranitidine (Zantac) Average Price by Company (2015-2020)
3.5 Manufacturers Ranitidine (Zantac) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Ranitidine (Zantac) Players (Opinion Leaders)
4 Global Ranitidine (Zantac) Market Size by Type
4.1 Global Ranitidine (Zantac) Historic Market Review by Type (2015-2020)
4.1.1 Global Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
4.1.2 Global Ranitidine (Zantac) Revenue Market Share by Type (2015-2020)
4.1.3 Global Ranitidine (Zantac) Price by Type (2015-2020)
4.2 Global Ranitidine (Zantac) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Ranitidine (Zantac) Sales Forecast by Type (2021-2026)
4.2.2 Global Ranitidine (Zantac) Revenue Forecast by Type (2021-2026)
4.2.3 Global Ranitidine (Zantac) Price Forecast by Type (2021-2026)
5 Global Ranitidine (Zantac) Market Size by Application
5.1 Global Ranitidine (Zantac) Historic Market Review by Application (2015-2020)
5.1.1 Global Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
5.1.2 Global Ranitidine (Zantac) Revenue Market Share by Application (2015-2020)
5.1.3 Global Ranitidine (Zantac) Price by Application (2015-2020)
5.2 Global Ranitidine (Zantac) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Ranitidine (Zantac) Sales Forecast by Application (2021-2026)
5.2.2 Global Ranitidine (Zantac) Revenue Forecast by Application (2021-2026)
5.2.3 Global Ranitidine (Zantac) Price Forecast by Application (2021-2026)
6 United States Ranitidine (Zantac) Market Facts & Figures
6.1 United States Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
6.2 United States Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
6.3 United States Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
7 Europe Ranitidine (Zantac) Market Facts & Figures
7.1 Europe Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
7.2 Europe Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
7.3 Europe Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
8 China Ranitidine (Zantac) Market Facts & Figures
8.1 China Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
8.2 China Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
8.3 China Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
9 Japan Ranitidine (Zantac) Market Facts & Figures
9.1 Japan Ranitidine (Zantac) Sales Market Share by Company (3015-3030)
9.2 Japan Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
9.3 Japan Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
10 Southeast Asia Ranitidine (Zantac) Market Facts & Figures
10.1 Southeast Asia Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
11 India Ranitidine (Zantac) Market Facts & Figures
11.1 India Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
11.2 India Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
11.3 India Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Ranitidine (Zantac) Business
12.1 Sanofi-Aventis
12.1.1 Sanofi-Aventis Corporation Information
12.1.2 Sanofi-Aventis Business Overview
12.1.3 Sanofi-Aventis Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi-Aventis Ranitidine (Zantac) Products Offered
12.1.5 Sanofi-Aventis Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Business Overview
12.2.3 GlaxoSmithKline Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Ranitidine (Zantac) Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Hi-Tech Pharmacal Co.
12.3.1 Hi-Tech Pharmacal Co. Corporation Information
12.3.2 Hi-Tech Pharmacal Co. Business Overview
12.3.3 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Hi-Tech Pharmacal Co. Ranitidine (Zantac) Products Offered
12.3.5 Hi-Tech Pharmacal Co. Recent Development
12.4 Sun Pharma
12.4.1 Sun Pharma Corporation Information
12.4.2 Sun Pharma Business Overview
12.4.3 Sun Pharma Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sun Pharma Ranitidine (Zantac) Products Offered
12.4.5 Sun Pharma Recent Development
12.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories)
12.5.1 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Corporation Information
12.5.2 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Business Overview
12.5.3 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Products Offered
12.5.5 Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Development
12.6 Dr. Reddy’s Laboratories Inc.
12.6.1 Dr. Reddy’s Laboratories Inc. Corporation Information
12.6.2 Dr. Reddy’s Laboratories Inc. Business Overview
12.6.3 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Products Offered
12.6.5 Dr. Reddy’s Laboratories Inc. Recent Development
12.7 Sandoz Inc. (part of Novartis AG)
12.7.1 Sandoz Inc. (part of Novartis AG) Corporation Information
12.7.2 Sandoz Inc. (part of Novartis AG) Business Overview
12.7.3 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Products Offered
12.7.5 Sandoz Inc. (part of Novartis AG) Recent Development
12.8 Strides (and Strides Arcolab international)
12.8.1 Strides (and Strides Arcolab international) Corporation Information
12.8.2 Strides (and Strides Arcolab international) Business Overview
12.8.3 Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Strides (and Strides Arcolab international) Ranitidine (Zantac) Products Offered
12.8.5 Strides (and Strides Arcolab international) Recent Development
12.9 Geri-Care Pharmaceuticals
12.9.1 Geri-Care Pharmaceuticals Corporation Information
12.9.2 Geri-Care Pharmaceuticals Business Overview
12.9.3 Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Geri-Care Pharmaceuticals Ranitidine (Zantac) Products Offered
12.9.5 Geri-Care Pharmaceuticals Recent Development
12.10 PAI Holdings, LLC
12.10.1 PAI Holdings, LLC Corporation Information
12.10.2 PAI Holdings, LLC Business Overview
12.10.3 PAI Holdings, LLC Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 PAI Holdings, LLC Ranitidine (Zantac) Products Offered
12.10.5 PAI Holdings, LLC Recent Development
12.11 Teva Pharmaceuticals
12.11.1 Teva Pharmaceuticals Corporation Information
12.11.2 Teva Pharmaceuticals Business Overview
12.11.3 Teva Pharmaceuticals Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Teva Pharmaceuticals Ranitidine (Zantac) Products Offered
12.11.5 Teva Pharmaceuticals Recent Development
12.12 Granules Pharmaceuticals Inc.
12.12.1 Granules Pharmaceuticals Inc. Corporation Information
12.12.2 Granules Pharmaceuticals Inc. Business Overview
12.12.3 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Granules Pharmaceuticals Inc. Ranitidine (Zantac) Products Offered
12.12.5 Granules Pharmaceuticals Inc. Recent Development
12.13 Glenmark Pharmaceuticals (and Glenmark Generics)
12.13.1 Glenmark Pharmaceuticals (and Glenmark Generics) Corporation Information
12.13.2 Glenmark Pharmaceuticals (and Glenmark Generics) Business Overview
12.13.3 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Products Offered
12.13.5 Glenmark Pharmaceuticals (and Glenmark Generics) Recent Development
12.14 Apotex Inc. (and Apotex Corporation)
12.14.1 Apotex Inc. (and Apotex Corporation) Corporation Information
12.14.2 Apotex Inc. (and Apotex Corporation) Business Overview
12.14.3 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Products Offered
12.14.5 Apotex Inc. (and Apotex Corporation) Recent Development
12.15 Hikma Pharmaceuticals (West-ward Pharmaceuticals)
12.15.1 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Corporation Information
12.15.2 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Business Overview
12.15.3 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Products Offered
12.15.5 Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Development
13 Ranitidine (Zantac) Manufacturing Cost Analysis
13.1 Ranitidine (Zantac) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Ranitidine (Zantac)
13.4 Ranitidine (Zantac) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Ranitidine (Zantac) Distributors List
14.3 Ranitidine (Zantac) Customers
15 Market Dynamics
15.1 Ranitidine (Zantac) Market Trends
15.2 Ranitidine (Zantac) Opportunities and Drivers
15.3 Ranitidine (Zantac) Market Challenges
15.4 Ranitidine (Zantac) Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Ranitidine (Zantac) Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Ranitidine (Zantac) Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Ranitidine (Zantac) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Ranitidine (Zantac) Sales (K Units) by Region (2015-2020)
Table 5. Global Ranitidine (Zantac) Sales Market Share by Region (2015-2020)
Table 6. Global Ranitidine (Zantac) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Ranitidine (Zantac) Revenue Share by Region (2015-2020)
Table 8. Global Ranitidine (Zantac) Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Ranitidine (Zantac) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Ranitidine (Zantac) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Ranitidine (Zantac) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Ranitidine (Zantac) (K Units) of Key Companies (2015-2020)
Table 13. Global Ranitidine (Zantac) Sales Share by Company (2015-2020)
Table 14. Global Ranitidine (Zantac) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Ranitidine (Zantac) Revenue Share by Company (2015-2020)
Table 16. Global Ranitidine (Zantac) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ranitidine (Zantac) as of 2019)
Table 17. Global Ranitidine (Zantac) Average Price (US$/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Ranitidine (Zantac) Manufacturing Sites and Area Served
Table 19. Manufacturers Ranitidine (Zantac) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Ranitidine (Zantac) Players
Table 22. Global Ranitidine (Zantac) Sales (K Units) by Type (2015-2020)
Table 23. Global Ranitidine (Zantac) Sales Share by Type (2015-2020)
Table 24. Global Ranitidine (Zantac) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Ranitidine (Zantac) Price (K Units) by Type (2015-2020)
Table 26. Global Ranitidine (Zantac) Sales Share by Type (2021-2026)
Table 27. Global Ranitidine (Zantac) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Ranitidine (Zantac) Revenue Share by Type (2021-2026)
Table 29. Global Ranitidine (Zantac) Price (K Units) by Type (2021-2026)
Table 30. Global Ranitidine (Zantac) Sales (K Units) by Application (2015-2020)
Table 31. Global Ranitidine (Zantac) Sales Share by Application (2015-2020)
Table 32. Global Ranitidine (Zantac) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Ranitidine (Zantac) Price (K Units) by Application (2015-2020)
Table 34. Global Ranitidine (Zantac) Sales (K Units) by Application (2021-2026)
Table 35. Global Ranitidine (Zantac) Sales Share by Application (2021-2026)
Table 36. Global Ranitidine (Zantac) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Ranitidine (Zantac) Revenue Share by Application (2021-2026)
Table 38. Global Ranitidine (Zantac) Price (K Units) by Application (2021-2026)
Table 39. United States Ranitidine (Zantac) Sales (K Units) by Company (2015-2020)
Table 40. United States Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
Table 41. United States Ranitidine (Zantac) Sales (K Units) by Type (2015-2020)
Table 42. United States Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
Table 43. United States Ranitidine (Zantac) Sales (K Units) by Application (2015-2020)
Table 44. United States Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
Table 45. Europe Ranitidine (Zantac) Sales (K Units) by Company (2015-2020)
Table 46. Europe Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
Table 47. Europe Ranitidine (Zantac) Sales (K Units) by Type (2015-2020)
Table 48. Europe Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
Table 49. Europe Ranitidine (Zantac) Sales (K Units) by Application (2015-2020)
Table 50. Europe Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
Table 51. China Ranitidine (Zantac) Sales (K Units) by Company (2015-2020)
Table 52. China Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
Table 53. China Ranitidine (Zantac) Sales (K Units) by Type (2015-2020)
Table 54. China Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
Table 55. China Ranitidine (Zantac) Sales (K Units) by Application (2015-2020)
Table 56. China Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
Table 57. Japan Ranitidine (Zantac) Sales (K Units) by Company (2015-2020)
Table 58. Japan Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
Table 59. Japan Ranitidine (Zantac) Sales (K Units) by Type (2015-2020)
Table 60. Japan Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
Table 61. Japan Ranitidine (Zantac) Sales (K Units) by Application (2015-2020)
Table 62. Japan Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Ranitidine (Zantac) Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Ranitidine (Zantac) Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Ranitidine (Zantac) Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
Table 69. India Ranitidine (Zantac) Sales (K Units) by Company (2015-2020)
Table 70. India Ranitidine (Zantac) Sales Market Share by Company (2015-2020)
Table 71. India Ranitidine (Zantac) Sales (K Units) by Type (2015-2020)
Table 72. India Ranitidine (Zantac) Sales Market Share by Type (2015-2020)
Table 73. India Ranitidine (Zantac) Sales (K Units) by Application (2015-2020)
Table 74. India Ranitidine (Zantac) Sales Market Share by Application (2015-2020)
Table 75. Sanofi-Aventis Corporation Information
Table 76. Sanofi-Aventis Description and Business Overview
Table 77. Sanofi-Aventis Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 78. Sanofi-Aventis Ranitidine (Zantac) Product
Table 79. Sanofi-Aventis Recent Development
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Ranitidine (Zantac) Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Hi-Tech Pharmacal Co. Corporation Information
Table 86. Hi-Tech Pharmacal Co. Description and Business Overview
Table 87. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 88. Hi-Tech Pharmacal Co. Ranitidine (Zantac) Product
Table 89. Hi-Tech Pharmacal Co. Recent Development
Table 90. Sun Pharma Corporation Information
Table 91. Sun Pharma Description and Business Overview
Table 92. Sun Pharma Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 93. Sun Pharma Ranitidine (Zantac) Product
Table 94. Sun Pharma Recent Development
Table 95. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Corporation Information
Table 96. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Description and Business Overview
Table 97. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 98. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Ranitidine (Zantac) Product
Table 99. Mylan Pharmaceuticals Inc. (and Mylan Laboratories) Recent Development
Table 100. Dr. Reddy’s Laboratories Inc. Corporation Information
Table 101. Dr. Reddy’s Laboratories Inc. Description and Business Overview
Table 102. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 103. Dr. Reddy’s Laboratories Inc. Ranitidine (Zantac) Product
Table 104. Dr. Reddy’s Laboratories Inc. Recent Development
Table 105. Sandoz Inc. (part of Novartis AG) Corporation Information
Table 106. Sandoz Inc. (part of Novartis AG) Description and Business Overview
Table 107. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 108. Sandoz Inc. (part of Novartis AG) Ranitidine (Zantac) Product
Table 109. Sandoz Inc. (part of Novartis AG) Recent Development
Table 110. Strides (and Strides Arcolab international) Corporation Information
Table 111. Strides (and Strides Arcolab international) Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 112. Strides (and Strides Arcolab international) Description and Business Overview
Table 113. Strides (and Strides Arcolab international) Ranitidine (Zantac) Product
Table 114. Strides (and Strides Arcolab international) Recent Development
Table 115. Geri-Care Pharmaceuticals Corporation Information
Table 116. Geri-Care Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 117. Geri-Care Pharmaceuticals Description and Business Overview
Table 118. Geri-Care Pharmaceuticals Ranitidine (Zantac) Product
Table 119. Geri-Care Pharmaceuticals Recent Development
Table 120. PAI Holdings, LLC Corporation Information
Table 121. PAI Holdings, LLC Description and Business Overview
Table 122. PAI Holdings, LLC Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 123. PAI Holdings, LLC Ranitidine (Zantac) Product
Table 124. PAI Holdings, LLC Recent Development
Table 125. Teva Pharmaceuticals Corporation Information
Table 126. Teva Pharmaceuticals Description and Business Overview
Table 127. Teva Pharmaceuticals Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 128. Teva Pharmaceuticals Ranitidine (Zantac) Product
Table 129. Teva Pharmaceuticals Recent Development
Table 130. Granules Pharmaceuticals Inc. Corporation Information
Table 131. Granules Pharmaceuticals Inc. Description and Business Overview
Table 132. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 133. Granules Pharmaceuticals Inc. Ranitidine (Zantac) Product
Table 134. Granules Pharmaceuticals Inc. Recent Development
Table 135. Glenmark Pharmaceuticals (and Glenmark Generics) Corporation Information
Table 136. Glenmark Pharmaceuticals (and Glenmark Generics) Description and Business Overview
Table 137. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 138. Glenmark Pharmaceuticals (and Glenmark Generics) Ranitidine (Zantac) Product
Table 139. Glenmark Pharmaceuticals (and Glenmark Generics) Recent Development
Table 140. Apotex Inc. (and Apotex Corporation) Corporation Information
Table 141. Apotex Inc. (and Apotex Corporation) Description and Business Overview
Table 142. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 143. Apotex Inc. (and Apotex Corporation) Ranitidine (Zantac) Product
Table 144. Apotex Inc. (and Apotex Corporation) Recent Development
Table 145. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Corporation Information
Table 146. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Description and Business Overview
Table 147. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2015-2020)
Table 148. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Ranitidine (Zantac) Product
Table 149. Hikma Pharmaceuticals (West-ward Pharmaceuticals) Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Ranitidine (Zantac) Distributors List
Table 153. Ranitidine (Zantac) Customers List
Table 154. Ranitidine (Zantac) Market Key Trends
Table 155. Ranitidine (Zantac) Key Opportunities and Drivers
Table 156. Ranitidine (Zantac) Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Ranitidine (Zantac) Product Picture
Figure 2. Global Ranitidine (Zantac) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Ranitidine (Zantac) Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacy Examples
Figure 7. Retail Pharmacy Examples
Figure 8. Online Pharmacy Examples
Figure 9. Global Ranitidine (Zantac) Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Ranitidine (Zantac) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Ranitidine (Zantac) Price Trends Growth Rate (2015-2026) (US$/Unit)
Figure 12. Global Ranitidine (Zantac) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Ranitidine (Zantac) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Ranitidine (Zantac) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Ranitidine (Zantac) Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Ranitidine (Zantac) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Ranitidine (Zantac) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Ranitidine (Zantac) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Ranitidine (Zantac) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Ranitidine (Zantac) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Ranitidine (Zantac) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Ranitidine (Zantac) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Ranitidine (Zantac) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Ranitidine (Zantac) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Ranitidine (Zantac) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Ranitidine (Zantac) Players Market Share by Revenue in Ranitidine (Zantac) 2015 & 2019
Figure 27. Ranitidine (Zantac) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Ranitidine (Zantac) Revenue Share by Type (2015-2020)
Figure 29. Global Ranitidine (Zantac) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Ranitidine (Zantac) Revenue Share by Application (2015-2020)
Figure 31. Global Ranitidine (Zantac) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Ranitidine (Zantac) Sales Market Share by Type in 2019
Figure 33. United States Ranitidine (Zantac) Sales Market Share by Type in 2019
Figure 34. Europe Ranitidine (Zantac) Sales Market Share by Company in 2019
Figure 35. Europe Ranitidine (Zantac) Sales Market Share by Type in 2019
Figure 36. Europe Ranitidine (Zantac) Sales Market Share by Application in 2019
Figure 37. China Ranitidine (Zantac) Sales Market Share by Company in 2019
Figure 38. China Ranitidine (Zantac) Sales Market Share by Type in 2019
Figure 39. China Ranitidine (Zantac) Sales Market Share by Application in 2019
Figure 40. Japan Ranitidine (Zantac) Sales Market Share by Company in 2019
Figure 41. Japan Ranitidine (Zantac) Sales Market Share by Type in 2019
Figure 42. Japan Ranitidine (Zantac) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Ranitidine (Zantac) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Ranitidine (Zantac) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Ranitidine (Zantac) Sales Market Share by Application in 2019
Figure 46. India Ranitidine (Zantac) Sales Market Share by Company in 2019
Figure 47. India Ranitidine (Zantac) Sales Market Share by Type in 2019
Figure 48. India Ranitidine (Zantac) Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Ranitidine (Zantac)
Figure 51. Manufacturing Process Analysis of Ranitidine (Zantac)
Figure 52. Ranitidine (Zantac) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed